| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| briakinumab | interleukin-12 subunit beta | biotech | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Crohn Disease[MeSHID:D003424] Multiple Sclerosis[MeSHID:D009103] Rheumatoid Arthritis[MeSHID:D001172] Autoimmune Diseases[MeSHID:D001327] Psoriasis[MeSHID:D011565] |
12.73 | investigational | unknown |
| briakinumab | interleukin-12 subunit beta | biotech | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Crohn Disease[MeSHID:D003424] Multiple Sclerosis[MeSHID:D009103] Rheumatoid Arthritis[MeSHID:D001172] Autoimmune Diseases[MeSHID:D001327] Psoriasis[MeSHID:D011565] |
12.73 | investigational | inhibitor |
| briakinumab | interleukin-23 subunit alpha | biotech | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Crohn Disease[MeSHID:D003424] Multiple Sclerosis[MeSHID:D009103] Rheumatoid Arthritis[MeSHID:D001172] Autoimmune Diseases[MeSHID:D001327] Psoriasis[MeSHID:D011565] |
7.07 | investigational | inhibitor |
| briakinumab | interleukin-23 subunit alpha | biotech | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Crohn Disease[MeSHID:D003424] Multiple Sclerosis[MeSHID:D009103] Rheumatoid Arthritis[MeSHID:D001172] Autoimmune Diseases[MeSHID:D001327] Psoriasis[MeSHID:D011565] |
7.07 | investigational | unknown |
| click here to return to the previous page | ||||||||